Your browser doesn't support javascript.
loading
FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer.
Walker, Amanda J; Wedam, Suparna; Amiri-Kordestani, Laleh; Bloomquist, Erik; Tang, Shengui; Sridhara, Rajeshwari; Chen, Wei; Palmby, Todd R; Fourie Zirkelbach, Jeanne; Fu, Wentao; Liu, Qi; Tilley, Amy; Kim, Geoffrey; Kluetz, Paul G; McKee, Amy E; Pazdur, Richard.
Afiliação
  • Walker AJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland. amanda.walker@fda.hhs.gov suparna.wedam@fda.hhs.gov.
  • Wedam S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland. amanda.walker@fda.hhs.gov suparna.wedam@fda.hhs.gov.
  • Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.
  • Bloomquist E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.
  • Tang S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.
  • Sridhara R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.
  • Chen W; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.
  • Palmby TR; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.
  • Fourie Zirkelbach J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.
  • Fu W; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.
  • Liu Q; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.
  • Tilley A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.
  • Kim G; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.
  • Kluetz PG; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.
  • McKee AE; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.
  • Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.
Clin Cancer Res ; 22(20): 4968-4972, 2016 Oct 15.
Article em En | MEDLINE | ID: mdl-27407089
Assuntos
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Piperazinas / Piridinas / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Aprovação de Drogas / Antineoplásicos Hormonais / Inibidores de Proteínas Quinases / Estradiol Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Piperazinas / Piridinas / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Aprovação de Drogas / Antineoplásicos Hormonais / Inibidores de Proteínas Quinases / Estradiol Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article